Active Ingredient History
Adenosine (symbol A) is an organic compound that occurs widely in nature in the form of diverse derivatives. The molecule consists of an adenine attached to a ribose via a β-N9-glycosidic bond. Adenosine is one of the four nucleoside building blocks of RNA (and its derivative deoxyadenosine is a building block of DNA), which are essential for all life. Its derivatives include the energy carriers adenosine mono-, di-, and triphosphate, also known as AMP/ADP/ATP. Cyclic adenosine monophosphate (cAMP) is pervasive in signal transduction. Adenosine is used as an intravenous medication for some cardiac arrhythmias. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Tachycardia, Supraventricular (approved 1989)
Acute Coronary Syndrome (Phase 4)
Adenosine (Phase 1/Phase 2)
Anesthesia and Analgesia (Early Phase 1)
Angina Pectoris (Phase 1/Phase 2)
Angina, Stable (Phase 3)
Angioplasty (Phase 3)
Atrial Fibrillation (Phase 3)
Atrioventricular Block (Phase 1)
Blood Pressure (Phase 4)
Bradycardia (Phase 1)
Cardiac Surgical Procedures (Phase 1/Phase 2)
Cardiomyopathies (Phase 4)
Cardiomyopathy, Hypertrophic (Phase 4)
Coronary Artery Disease (Phase 3)
Coronary Stenosis (Phase 3)
Heart Defects, Congenital (Phase 1/Phase 2)
Heart Transplantation (Phase 3)
Hypertension (Phase 4)
Infant, Premature (Phase 4)
Inflammation (Phase 1)
Liver Neoplasms (Phase 1/Phase 2)
Lung Diseases (Phase 3)
Magnetic Resonance Imaging (Early Phase 1)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 4)
Myocardial Reperfusion Injury (Phase 1/Phase 2)
No-Reflow Phenomenon (Phase 4)
Pain (Phase 2)
Pathologic Processes (Phase 2)
Percutaneous Coronary Intervention (Phase 4)
Respiratory Distress Syndrome (Phase 2)
Tachycardia (Phase 3)
Takotsubo Cardiomyopathy (Phase 2)
Vascular Diseases (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
